Litcius/Paper detail

A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trial

David V. Glidden, Oliver Stirrup, David Dunn

2020The Lancet HIV24 citationsDOIOpen Access PDF

Topics & Concepts

EmtricitabineMedicinePre-exposure prophylaxisHuman immunodeficiency virus (HIV)Clinical trialIncidence (geometry)Tenofovir alafenamideRandomized controlled trialMen who have sex with menTenofovirInternal medicineVirologyViral loadAntiretroviral therapySyphilisOpticsPhysicsHIV/AIDS Research and InterventionsHIV Research and TreatmentHIV, Drug Use, Sexual Risk
A Bayesian averted infection framework for PrEP trials with low numbers of HIV infections: application to the results of the DISCOVER trial | Litcius